Abstract
Elaiophylins belong to a special family of 16-membered macrodiolides with C2-symmetry. They have exhibited remarkable biological activities, such as antimicrobial, anthelmintic, anticancer, immunosuppressive, anti-inflammatory, antiviral, and α-glucosidase inhibitory activities. A member of elaiophylins, efomycin M, is as a specific small molecule inhibitor of selectin in preclinical trial for the treatment of psoriasis, ischemia-reperfusion, and allergy. The biosynthetic investigation of elaiophylins has uncovered a unique thioesterase, which is responsible for the formation of C2-symmetric diolide. We herein summarize the natural occurrence, bioactivity, and biosynthesis of elaiophylins covering the literatures from 1959 to 2019. Hopefully, this review will inspire further research interests of these compounds and encourage the discovery of new analogues by metabolic engineering or genome mining.
Funder
National Natural Science Foundation of China
Science and Technology Commission of Shanghai Municipality
Subject
Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science
Reference51 articles.
1. The Biosynthetic Logic of Polyketide Diversity
2. Macrolide Antibiotics: Chemistry, Biology, and Practice;Ōmura,2003
3. Melanosporin and elaiophylin, new antibiotics from Streptomyces melanosporus (sive melonsporofaciens) n. sp.;Arcamone;G. Microbiol.,1959
4. Conglobatin, a novel macrolide dilactone from Streptomyces conglobatus ATCC 31005.
5. Antimalarial 20-membered macrolides from Streptomyces sp. BCC33756
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献